Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice

Clinical trial NCT05250011 · COMPLETED

Trial details

NCT number: NCT05250011
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Heart Failure, Reduced Ejection Fraction

Start date: 2022-04-19
Primary completion: 2024-04-15
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.